المؤلفون: Guenther LM, Dharia NV, Ross L, Saur Conway A, Robichaud AL, Catlett JL, Wechsler C, Frank ES, Goodale AB, Church AJ, Tseng YY, Guha R, McKnight C, Janeway KA, Boehm JS, Mora J, Davis MI, Alexe G, Piccioni F, Stegmaier K

المصدر: CLINICAL CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e89c0c7bf876fd4c61c36ffab070477
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15250

المؤلفون: Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N, Janeway, Katherine A, Barkauskas, Donald A, Krailo, Mark D, Meyers, Paul A, Schwartz, Cindy L, Ebb, David H, Seibel, Nita L, Grier, Holcombe E, Gorlick, Richard, Marina, Neyssa

المصدر: Cancer (0008543X); Sep2012, Vol. 118 Issue 18, p4597-4605, 9p

المؤلفون: Nelson MV; Children's National Hospital, Washington, DC 20010, United States., Kim A; Children's National Hospital, Washington, DC 20010, United States., Williams PM; Frederick National Laboratory for Cancer Research, Frederick MD 21701, United States., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD 20892, United States., Coffey BD; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD 20892, United States., Reid JM; Mayo Clinic, Rochester, MN 55905, United States., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA 91016, United States., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, United States., Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, United States., Ramirez NC; Biopathology Center, Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, United States., Jaju A; Ann and Robert H. Lurie Children's Hospital, Chicago, IL 60611, United States., Fox E; St Jude Children's Research Hospital, Memphis, TN 38105, United States., Weigel BJ; University of Minnesota/Masonic Cancer Center, Minneapolis, MD 55455, United States., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA 98105, United States., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Takebe N; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, United States., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States., Seibel NL; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD 20892, United States., Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030, United States.

المصدر: The oncologist [Oncologist] 2024 Aug 05; Vol. 29 (8), pp. 723-e1093.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins B-raf*/genetics , Vemurafenib*/therapeutic use , Vemurafenib*/administration & dosage , Mutation*, Humans ; Male ; Female ; Child ; Adolescent ; Young Adult ; Adult ; Child, Preschool ; Neoplasms/drug therapy ; Neoplasms/genetics

المؤلفون: Venkataraman V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Martin-Giacalone BA; Washington University School of Medicine, St Louis, MO.; Alvin J. Siteman Cancer Center, St Louis, MO., Drake BF; Washington University School of Medicine, St Louis, MO.; Alvin J. Siteman Cancer Center, St Louis, MO., Salmi L; Beth Israel Deaconess Medical Center, Boston, MA., Claus EB; Department of Biostatistics, Yale School of Public Health, New Haven, CT.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Schuster ALR; The Ohio State University College of Medicine, Columbus, OH., Bridges JFP; The Ohio State University College of Medicine, Columbus, OH., Lenz HJ; Keck School of Medicine of USC, Los Angeles, CA.; Norris Comprehensive Cancer Center, Los Angeles, CA., Willman CL; Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN.; The University of New Mexico School of Medicine, Albuquerque, NM., Diehl D; Count Me In, The Broad Institute of MIT and Harvard, Boston, MA., Janeway KA; Harvard Medical School, Boston, MA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., Mack JW; Harvard Medical School, Boston, MA.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA., George S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 02, pp. JCO2400347. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

المؤلفون: Forrest SJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Suzanne_Forrest@dfci.harvard.edu., Gupta H; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ward A; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Li YY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Doan D; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Al-Ibraheemi A; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Alexandrescu S; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Collins NB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Chi SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wright KD; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kumari P; Dana-Farber Cancer Institute, Boston, MA, USA., Mazor T; Dana-Farber Cancer Institute, Boston, MA, USA., Ligon KL; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Shivdasani P; Brigham and Women's Hospital, Boston, MA, USA., Manam M; Boston Children's Hospital, Boston, MA, USA., MacConaill LE; Brigham and Women's Hospital, Boston, MA, USA., Ceca E; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Benich SN; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA, USA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA, USA., Guidry Auvil JM; National Cancer Institute, Bethesda, MD, USA., Cerami E; Dana-Farber Cancer Institute, Boston, MA, USA., Rollins BJ; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Meyerson ML; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lindeman NI; Weill Cornell Medical College, New York, NY, USA., Johnson BE; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Cherniak AD; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Church AJ; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Katherine_Janeway@dfci.harvard.edu.

المصدر: Nature communications [Nat Commun] 2024 Jul 11; Vol. 15 (1), pp. 5837. Date of Electronic Publication: 2024 Jul 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/genetics , Neoplasms*/drug therapy , Precision Medicine*/methods , Information Dissemination* , High-Throughput Nucleotide Sequencing*/methods, Humans ; Child ; Male ; Child, Preschool ; Female ; Adolescent ; Infant ; Mutation ; Clinical Trials as Topic ; Molecular Targeted Therapy/methods ; Genomics/methods ; Infant, Newborn

المؤلفون: Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Pinkney K; Department of Hematology-Oncology, Memorial Regional Hospital/Joe Dimaggio Children's Hospital, Hollywood, FL, United States., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Roy-Chowdhuri S; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patton DR; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Coffey BD; Center for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States., Reid JM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States., Piao J; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA, United States., Alonzo TA; Department of Biostatistics, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States., Berg SL; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, United States., Ramirez NC; Biopathology Center, Nationwide Children's Hospital, Columbus, OH, United States., Fox E; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States., Weigel BJ; Department of Pediatrics, Hem/Onc/BMT, University of Minnesota Medical Center, Pediatric Hematology Oncology, Minneapolis, MN, United States., Hawkins DS; Department of Hematology-Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States., Mooney MM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Janeway KA; Department of Pediatrics, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, United States., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, United States., Parsons DW; Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, United States.

المصدر: The oncologist [Oncologist] 2024 Jul 05; Vol. 29 (7), pp. 638-e952.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: DNA Repair*/drug effects , DNA Repair*/genetics , Neoplasms*/drug therapy , Neoplasms*/genetics , Phthalazines*/therapeutic use , Phthalazines*/adverse effects , Phthalazines*/administration & dosage , Piperazines*/therapeutic use , Piperazines*/administration & dosage , Piperazines*/adverse effects, Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Young Adult ; Ataxia Telangiectasia Mutated Proteins/genetics ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; DNA Damage/drug effects ; DNA-Binding Proteins/genetics ; Germ-Line Mutation ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects

المؤلفون: Ilcisin L; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Han R; Children's Oncology Group, Monrovia, CA, USA., Krailo M; Children's Oncology Group, Arcadia, CA, USA.; Department of Population and Public Health Sciences Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Shulman DS; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Weil BR; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Weldon CB; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Umaretiya P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Aziz-Bose R; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenzang KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reed DR; Division of Pediatric Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Randall RL; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, USA., Nadel H; Division of Radiology, Lucille Packard Children's Hospital at Stanford University, Stanford, CA, USA., Binitie O; Department of Surgery, Moffitt Cancer Center, Tampa, FL, USA., Dubois SG; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Bona K; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Jun 26. Date of Electronic Publication: 2024 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

المؤلفون: Vo KT; Department of Pediatrics, University of California, San Francisco School of Medicine, UCSF Benioff Children's Hospital, San Francisco, CA., Sabnis AJ; Department of Pediatrics, University of California, San Francisco School of Medicine, UCSF Benioff Children's Hospital, San Francisco, CA., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Reid JM; Mayo Clinic, Rochester, MN., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX., Jaju A; Ann and Robert H. Lurie Children's Hospital, Chicago, IL., Fox E; St Jude Children's Research Hospital, Memphis, TN., Weigel BJ; Department of Pediatrics, University of Minnesota, Minneapolis, MN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Seibel NL; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.

المصدر: JCO precision oncology [JCO Precis Oncol] 2024 Jun; Vol. 8, pp. e2400103.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/genetics, Humans ; Adolescent ; Child ; Female ; Male ; Young Adult ; Child, Preschool ; Infant ; United States ; Mitogen-Activated Protein Kinases/genetics ; National Cancer Institute (U.S.) ; MAP Kinase Signaling System/drug effects ; MAP Kinase Signaling System/genetics ; Aminopyridines ; Pyrroles

المؤلفون: Hegde M; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. mghegde@bcm.edu.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA. mghegde@bcm.edu.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. mghegde@bcm.edu.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. mghegde@bcm.edu., Navai S; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., DeRenzo C; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Joseph SK; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Sanber K; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Wu M; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Gad AZ; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA., Janeway KA; Department of Pediatrics, Boston Children's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Campbell M; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Mullikin D; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Nawas Z; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Robertson C; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA., Mathew PR; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Zhang H; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA., Mehta B; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA., Bhat RR; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Major A; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA., Shree A; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Gerken C; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Kalra M; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Chakraborty R; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Thakkar SG; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA., Dakhova O; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA., Salsman VS; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Grilley B; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Lapteva N; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA., Gee A; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA., Dotti G; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Bao R; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Salem AH; Department of Clinical Pharmacy, Ain Shams University, Cairo, Egypt., Wang T; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Brenner MK; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Heslop HE; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Wels WS; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany., Hicks MJ; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA., Gottschalk S; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA., Ahmed N; Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. nahmed@bcm.edu.; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, TX, USA. nahmed@bcm.edu.; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. nahmed@bcm.edu.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. nahmed@bcm.edu.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. nahmed@bcm.edu.

المصدر: Nature cancer [Nat Cancer] 2024 Jun; Vol. 5 (6), pp. 880-894. Date of Electronic Publication: 2024 Apr 24.

نوع المنشور: Journal Article; Clinical Trial, Phase I

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/therapy , Sarcoma*/immunology , Receptor, ErbB-2* , Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/adverse effects , Receptors, Chimeric Antigen*/immunology, Humans ; Middle Aged ; Female ; Male ; Adult ; Aged ; T-Lymphocytes/immunology ; Lymphocyte Depletion/methods ; Prospective Studies ; Vidarabine/analogs & derivatives ; Vidarabine/administration & dosage ; Vidarabine/therapeutic use ; Cyclophosphamide/therapeutic use ; Cyclophosphamide/administration & dosage ; Treatment Outcome

المؤلفون: Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Collins RL; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Crowdis J; Harvard Medical School, Boston, MA, USA., Garza A; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Jones JK; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Walker M; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sanchis-Juan A; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Whelan C; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Pierce-Hoffman E; Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA., Talkowski M; Harvard Medical School, Boston, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Brand H; Harvard Medical School, Boston, MA, USA.; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Haigis K; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham & Women's Hospital and Harvard Medical School, Boston, MA, USA., LoPiccolo J; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., AlDubayan SH; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA.; College of Medicine, King Saudi bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Gusev A; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Crompton BD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Van Allen EM; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 29. Date of Electronic Publication: 2024 Apr 29.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE